Restoration of euthyroidism does not improve cardiovascular risk factors in patients with subclinical hypothyroidism in the short term

Journal of Endocrinological Investigation

Volumn 29, Issue 6, 2006, Pages 505-510

  Beyhan, Z ^a   Erturk K ^a   Uckaya G ^a   Bolu, E ^a   Yaman, H ^a   Kutlu, M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cardiovascular risk factors; Levothyroxine replacement; Subclinical hypothyroidism

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LEVOTHYROXINE; LIOTHYRONINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SUBCLINICAL HYPOTHYROIDISM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 33746704923     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344139     Document Type: Article

References (26)

1. Ridgway EC, Cooper DS, Walker H, Rodbard D, Maloof F. Peripheral responses to thyroid hormone before and after l-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1981, 53: 1238-42.
2. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: Rotterdam study. Ann Intern Med 2000, 132: 270-8.
3. Lindeman RD, Romero LJ, Schade DS, Wayne S, Baumgartner RN, Garry PJ. Impact of SH on serum homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in New Mexico Elder Health Survey. Thyroid 2003, 13: 595-600.
4. U.S. Preventive Services Task Force: Screening for thyroid disease: Recommendation statement. Ann Intern Med 2004, 140: 125-7.
5. Helfand M. Screening for subclinical thyroid dysfunction in non-pregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004, 140: 128-41.
6. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA 2004, 291: 228-38.
7. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease. JAMA 2003, 290: 932-40.
8. Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000, 85: 2993-3001.
9. Yildirimkaya M, Ozata M, Yilmaz K, Kilinc C, Gundogan MA, Kutluay T. Lipoprotein (a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocr J 1996, 43: 731-6.
10. Efstathiadou Z, Bitsis S, Milionis HJ, et al. Lipid profile in subclinical hypothyroidism. Is L-thyroxine substitution beneficial? Eur J Endocrinol 2001, 145: 705-10.
11. Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ, Ozden M. Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Endocr Res 2003, 29: 307-16.
12. Deicher R, Vierhapper H. Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid 2002, 12: 733-6.
13. Christ-Crain M, Meier C, Guglielmetti M, et al. Elevated C-reactive protein homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double blind, placebo controlled trial. Atherosclerosis 2003, 166: 379-86.
14. Perez A, Cubero JM, Sucunza N, et al. Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism. Metabolism 2004, 53: 1512-5.
15. Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in SH: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002, 87: 1533-8.
16. Milionis HJ, Efstathiadou Z, Tselepis AD, et al. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with SH: effect of treatment with levothyroxine. Thyroid 2003, 13: 365-9.
17. Kung AW, Pang RW, Janus ED. Elevated serum lipoprotein (a) in SH. Clin Endocrinol (Oxf) 1995, 43: 445-9.
18. Jublanc C, Bruckert E, Giral P, et al. Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP. Atherosclerosis 2004, 172: 7-11.
19. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence of causality from a meta-analysis. BMJ 2002, 325: 1202-8.
20. Hussein WI, Green R, Jacobsen DW, Faiman C. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Ann Intern Med 1999, 131: 348-51.
21. Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger P, Tabarin A. Homocysteine, hypothyroidism, and effect of thyroid hormone replacement. Thyroid 1999, 9: 1163-6.
22. Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002, 12: 421-5.
23. Lien EA, Nedrebo BG, Varhaug JE, Nygard O, Aagvaag A, Ueland PM. Plasma total homocysteine levels during short-term iatrogenic hypothyroidism. J Clin Endocrinol Metab 2000, 85: 1049-53.
24. Nedrebo BG, Nygard O, Ueland PM, Lien EA. Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. Clin Chem 2001, 47: 1738-41.
25. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004, 24: 1-13.
26. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005, 90: 581-93.